Oxford begins first human trial of Bundibugyo Ebola vaccine
The University of Oxford has launched the first human trials for a Bundibugyo Ebola vaccine amidst an ongoing outbreak in Congo.
Evidence dossier
Intelligence passport
Measured timeline
- Detected The first matching coverage entered the Archynetys cluster.
- Latest coverage observed Most recent article currently attached to this story cluster.
- Peak measured velocity The recorded velocity reached 5.
- Evidence threshold reached The story had enough independent coverage for an explanatory brief.
- Outcome review added Archynetys revisited the signal after coverage cooled.
Source diversity sample: Bloomberg.com · The Telegraph · University of Oxford · Sky News · CEPI · BBC · Reuters.
How this dossier is built: methodology · AI policy · corrections.
📍 How it ended
Oxford launched the first human trials of a Bundibugyo ebolavirus vaccine. The trials began in the UK and Uganda amid a continuing outbreak in Congo.
The story quieted without a definitive conclusion in the coverage.
Epilogue added 45d ago, after coverage quieted.
The obvious questions
Who is conducting the vaccine trials?
The trials are being conducted by the Oxford Vaccine Group.
Which organization is backing the trial?
The trial is backed by CEPI.
Where is the Ebola outbreak currently occurring?
According to coverage, an outbreak is continuing in Congo.
🌍 Language by language
This story first appeared in 🇧🇷 Portuguese coverage — 8.4 hours before Archynetys detected it in English news.
Detected by matching proper nouns and figures that survive translation. Times reflect when each edition's coverage was first indexed.
The story so far
The Oxford Vaccine Group has initiated the first human trials for a vaccine targeting the Bundibugyo ebolavirus. The trial is backed by CEPI and comes eight weeks into an Ebola emergency, with an outbreak continuing in Congo.
Coverage from Reuters, Bloomberg, and the BBC emphasizes the start of these trials in the UK. The Telegraph highlights a Ugandan city as a critical location in the race for the new vaccine's success.
Future developments center on the results of these human trials and the response to the continuing outbreak in Congo.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 45d ago.
Coverage (8)
- First Human Trial of Bundibugyo Ebola Vaccine Begins as Congo Outbreak Continues Bloomberg.com · 47d ago
- First Human Trial of Bundibugyo Ebola Vaccine Begins Bloomberg.com · 47d ago
- The Ugandan city where the race for a new Ebola vaccine will be won or lost The Telegraph · 47d ago
- Oxford's Bundibugyo ebolavirus response University of Oxford · 47d ago
- Human trials of new Ebola vaccine set to begin in UK Sky News · 47d ago
- CEPI-backed Bundibugyo ebolavirus vaccine trial launched by Oxford Vaccine Group CEPI · 47d ago
- UK starts first vaccine trial, eight weeks into Ebola emergency BBC · 47d ago
- Oxford begins first human trial of Bundibugyo Ebola vaccine Reuters · 47d ago
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Topics
From around our network
Related trends
Congo's Ebola outbreak records one of its highest weekly death tolls yet
The Democratic Republic of the Congo is experiencing one of its deadliest weeks yet in the ongoing Ebola outbreak.
Congo’s Ebola outbreak reaches 5,000 cases as it outpaces response efforts at unprecedented speed
The Ebola outbreak in Congo has reached 5,000 cases, outpacing response efforts at an unprecedented speed.
Congo: Ebola cases rising at record pace
Ebola is killing one person every 30 minutes in Congo, as cases surge at a record pace
Congo says 2,000 people have died in its Ebola outbreak, the fastest growing on record
The Democratic Republic of Congo reports 2,000 deaths in an Ebola outbreak now identified as the fastest-growing in recorded history.
WHO says Congo’s Ebola outbreak started months before it was declared
The World Health Organization reports that the current Ebola outbreak in Congo was active for months prior to its formal declaration.
More pregnant women are dying in Congo as they avoid hospitals over Ebola
Ebola outbreak in Congo is now the second-deadliest in history, with 1,700 dead and pregnant women avoiding hospitals.
Open prediction lab
Can you beat the machine?
Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.
📬 The daily trend digest
The world's top trends, once a day. No spam, one-click unsubscribe.